Pages Menu
FacebookTwitterPinterestRss
Categories Menu

CTD Holdings

CTD Holdings


FDA Grants Fast Track Designation for
Trappsol (R) Cyclo(TM) in
Drug Development Program for NPC

CLICK HERE FOR FULL ANNOUNCEMENT

01/17/2017 jjb

CTD Holdings Files Clinical Trial Application
with Italian Drug Agency to Continue Advancing
Trappsol(R) Cyclo(TM) 
Drug Development Program
to Treat Niemann-Pick Disease Type C

CLICK HERE FOR FULL ANNOUNCEMENT

12/22/2016 jjb

CTD HOLDINGS IV TRAPPSOL CYCLO STUDY

The NNPDF Central Office has received notice that
CTD’s US trial parameters for the IV Trappsol Cyclo study in NPC
are now published at Clinical Trials.Gov.


CTD HOLDINGS PRESS RELEASE

CTD Holdings Announces MHRA Approval of Clinical Trial
Application for Treatment of NPC With Trappsol(R) Cyclo(TM)

CLICK HERE FOR FULL RELEASE


09/29/2016 jjb